Lindbrook Capital, LLC Athenex, Inc. Transaction History

Lindbrook Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$4.08 - $14.75 $18,360 - $66,375	-4,500 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$11.06 - $14.01 $27,650 - $35,025	2,500 Added 125.0%	4,500 $50,000
Q3 2020 Nov 03, 2020	BUY	$10.26 - $14.55 $20,520 - $29,100	2,000 New	2,000 $24,000
Q2 2020 Jul 27, 2020	SELL	$7.11 - $13.76 $3,555 - $6,880	-500 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$5.71 - $15.85 $19,985 - $55,475	-3,500 Reduced 87.5%	500 $4,000
Q4 2019 Jan 27, 2020	BUY	$9.6 - $17.75 $38,400 - $71,000	4,000 New	4,000 $61,000
Q3 2019 Oct 31, 2019	SELL	$12.16 - $21.0 $48,640 - $84,000	-4,000 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$9.44 - $19.8 $37,760 - $79,200	4,000 New	4,000 $79,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.